89 related articles for article (PubMed ID: 9403046)
21. Sentinel lymph node mapping in the management of high risk malignant melanoma.
Donckier V; Vereecken P; Blocklet D; Laporte M; Velu T; Heenen M; Van Geertruyden J
Acta Chir Belg; 1999 Dec; 99(6):295-8. PubMed ID: 10674132
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy in head and neck squamous cell carcinoma.
Pitman KT; Johnson JT; Brown ML; Myers EN
Laryngoscope; 2002 Dec; 112(12):2101-13. PubMed ID: 12461328
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic mapping and sentinel lymph node biopsy in the staging of melanoma.
Edwards MJ; Martin KD; McMasters KM
Surg Oncol; 1998; 7(1-2):51-7. PubMed ID: 10421506
[TBL] [Abstract][Full Text] [Related]
25. Timing of sentinel lymph node mapping after lymphoscintigraphy.
White DC; Schuler FR; Pruitt SK; Culhane DK; Seigler HF; Coleman RE; Tyler D
Surgery; 1999 Aug; 126(2):156-61. PubMed ID: 10455878
[TBL] [Abstract][Full Text] [Related]
26. Lymphatic mapping with sentinel node biopsy in pediatric patients.
Neville HL; Andrassy RJ; Lally KP; Corpron C; Ross MI
J Pediatr Surg; 2000 Jun; 35(6):961-4. PubMed ID: 10873044
[TBL] [Abstract][Full Text] [Related]
27. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases.
Godellas CV; Berman CG; Lyman G; Cruse CW; Rapaport D; Heller R; Wang X; Glass F; Fenske N; Messina J
Am Surg; 1995 Feb; 61(2):97-101. PubMed ID: 7856986
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
Faries MB; Bleicher RJ; Ye X; Essner R; Morton DL
Arch Surg; 2004 Aug; 139(8):870-6; discussion 876-7. PubMed ID: 15302697
[TBL] [Abstract][Full Text] [Related]
29. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.
Lukowsky A; Bellmann B; Ringk A; Winter H; Audring H; Fenske S; Sterry W
J Invest Dermatol; 1999 Oct; 113(4):554-9. PubMed ID: 10504440
[TBL] [Abstract][Full Text] [Related]
30. Towards quality assurance of the sentinel node procedure in malignant melanoma patients: a single institution evaluation and a European survey.
Bongers V; Borel Rinkes IH; Barneveld PC; Canninga-van Dijk MR; van Rijk PP; van Vloten WA
Eur J Nucl Med; 1999 Feb; 26(2):84-90. PubMed ID: 9933341
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy in thin melanoma patients.
Hershko DD; Robb BW; Lowy AM; Ahmad SA; Ramadas GH; Soldano DA; Sussman JJ
J Surg Oncol; 2006 Mar; 93(4):279-85. PubMed ID: 16496355
[TBL] [Abstract][Full Text] [Related]
32. Sentinel node biopsies in melanoma patients: a protocol for accurate, efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR.
van der Velde-Zimmermann D; Schipper ME; de Weger RA; Hennipman A; Borel Rinkes IH
Ann Surg Oncol; 2000; 7(1):51-4. PubMed ID: 10674449
[TBL] [Abstract][Full Text] [Related]
33. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
[TBL] [Abstract][Full Text] [Related]
34. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe.
Mudun A; Murray DR; Herda SC; Eshima D; Shattuck LA; Vansant JP; Taylor AT; Alazraki NP
Radiology; 1996 Apr; 199(1):171-5. PubMed ID: 8633142
[TBL] [Abstract][Full Text] [Related]
35. Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients.
Lenisa L; Santinami M; Belli F; Clemente C; Mascheroni L; Patuzzo R; Gallino G; Bergonzi M; Rao S; Polverelli M; Morelli R; Landi G; Cascinelli N
J Exp Clin Cancer Res; 1999 Mar; 18(1):69-74. PubMed ID: 10374681
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary lymphatic mapping in dogs: use of technetium sulfur colloid and isosulfan blue for pulmonary sentinel lymph node mapping in dogs.
Nwogu CE; Kanter PM; Anderson TM
Cancer Invest; 2002; 20(7-8):944-7. PubMed ID: 12449726
[TBL] [Abstract][Full Text] [Related]
37. Two phase scintigraphic mapping of lymphatic drainage in cutaneous melanoma using 99mTc-sulfur microcolloid/99mTc antimelanoma antibody.
Limouris GS; Voliotopoulos V; Kondi-Paphiti A; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1667-9. PubMed ID: 9179215
[TBL] [Abstract][Full Text] [Related]
38. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid.
Goldfarb LR; Alazraki NP; Eshima D; Eshima LA; Herda SC; Halkar RK
Radiology; 1998 Aug; 208(2):505-9. PubMed ID: 9680583
[TBL] [Abstract][Full Text] [Related]
39. [Optimization of lymphoscintigraphy in sentinel node biopsy in the staging of malignant melanoma].
Tartaglione G; Potenza C; Caggiati A; Gabrielli F; Pagan M
Radiol Med; 2000 Nov; 100(5):367-71. PubMed ID: 11213417
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node mapping in melanoma of the ear.
Wey PD; De La Cruz C; Goydos JS; Choi ML; Borah GL
Ann Plast Surg; 1998 May; 40(5):506-9. PubMed ID: 9600436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
